Table 1 Clinical data of patients with OSCC
# (%) | Median age at diagnosis (range) | Observation time (range) | ||||
|---|---|---|---|---|---|---|
Women | 17 (0.24) | 57 (48–76) years | 16 (3–27) months | |||
Men | 54 (0.76) | 58 (36–84) years | 14 (3–24) months | |||
Deceased | 10 (0.14) | |||||
Current status unknown | 14 (0.2) | |||||
Tumour location | # (%) | |||||
Hypopharinx | 5 (0.07) | |||||
Larynx | 2 (0.03) | |||||
Lips | 1 (0.01) | |||||
Mouth: | 36 (0.51) | |||||
Tongue | 14 (0.20) | |||||
Floor of the mouth | 13 (0.18) | |||||
Retromolar trigone | 3 (0.04) | |||||
Lower alveolus | 3 (0.04) | |||||
Buccal mucosa | 2 (0.03) | |||||
Upper alveolus | 1 (0.01) | |||||
Oropharynx | 27 (0.38) | |||||
TNM classification | ||||||
Tumour | # (%) | Lymph node status | # (%) | Distant metastasis | # (%) | |
Tis | 1 (0.01) | N0 | 27 (0.38) | M0 | 69 (0.97) | |
T1 | 5 (0.07) | N1 or higher | 44 (0.62) | M1 | 2 (0.03) | |
T2 | 20 (0.28) | |||||
T3 | 11 (0.25) | |||||
T4 | 34 (0.48) | |||||
Disease stage | # (%) | Histologic grading | # (%) | |||
0 | 1 (0.01) | Carcinoma in situ | 2 (0.03) | |||
I | 4 (0.06) | Grade 1 | 12 (0.17) | |||
II | 11 (0.15) | Grade 2 | 45 (0.63) | |||
III | 7 (0.10) | Grade 3 | 12 (0.17) | |||
IVA | 35 (0.49) | |||||
IVB | 11 (0.15) | |||||
IVC | 2 (0.03) | |||||